Showing results (1441-1450 of 1,873) with videos related to
Sort By:
Pageof 188
Oncogenesis|July 1, 2014
MUC1 regulates cyclin D1 gene expression through p120 catenin and β-cateninX Liu, T C Caffrey, M M Steele, et al.JCI Insight|March 22, 2023
JAK-STAT activation contributes to cytotoxic T cell-mediated basal cell death in human chronic lung allograft dysfunctionAaditya Khatri, Jamie L Todd, Fran L Kelly, et al.Antimicrobial Agents and Chemotherapy|August 25, 2010
Identification and characterization of four azole-resistant erg3 mutants of Candida albicansClaire M Martel, Josie E Parker, Oliver Bader, et al.Antimicrobial Agents and Chemotherapy|July 14, 2010
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51)Andrew G S Warrilow, Claire M Martel, Josie E Parker, et al.Human Molecular Genetics|September 1, 1997
Functional correction of short-chain acyl-CoA dehydrogenase deficiency in transgenic mice: implications for gene therapy of human mitochondrial enzyme deficienciesC L Kelly, W J Rhead, W K Kutschke, et al.Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic AcidKorrapati V Sathyasaikumar, Francesca M Notarangelo, Deanna L Kelly, et al.Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Synchronization of energy consumption by human societies throughout the HoloceneJacob Freeman, Jacopo A Baggio, Erick Robinson, et al.Schizophrenia Research|November 26, 2008
Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidoneDeanna L Kelly, Heidi J Wehring, Jared Linthicum, et al.American Journal of Medical Genetics|February 24, 2001
Frequency of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Australian patients with spinocerebellar ataxiaE Storey, D du Sart, J H Shaw, et al.International Immunology|April 28, 2000
B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokineM A Sleeman, J K Fraser, J G Murison, et al.Pageof 188